The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data

The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data

Background: The rapid vaccination campaign against COVID-19 in Israel relied on the BNT162b2 vaccine. We performed a longitudinal analysis of multiple cohorts, using individual data, to evaluate the effectiveness of the vaccine against new and breakthrough cases. Methods: We estimated vaccine effect...

Full description

Bibliographic Details
Main Authors: Aharona Glatman-Freedman, Michal Bromberg, Rita Dichtiar, Yael Hershkovitz, Lital Keinan-Boker
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:EBioMedicine
Subjects:
Vaccine effectiveness
SARS-CoV-2
COVID-19
Breakthrough cases
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396421003674

Similar Items

Similar Items